IBDEI0P4 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11208,1,3,0)
 ;;=3^SCC Neop Skin,Right Upper Eyelid
 ;;^UTILITY(U,$J,358.3,11208,1,4,0)
 ;;=4^C44.1221
 ;;^UTILITY(U,$J,358.3,11208,2)
 ;;=^5157261
 ;;^UTILITY(U,$J,358.3,11209,0)
 ;;=C44.1222^^77^726^27
 ;;^UTILITY(U,$J,358.3,11209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11209,1,3,0)
 ;;=3^SCC Neop Skin,Right Lower Eyelid
 ;;^UTILITY(U,$J,358.3,11209,1,4,0)
 ;;=4^C44.1222
 ;;^UTILITY(U,$J,358.3,11209,2)
 ;;=^5157262
 ;;^UTILITY(U,$J,358.3,11210,0)
 ;;=C44.1291^^77^726^28
 ;;^UTILITY(U,$J,358.3,11210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11210,1,3,0)
 ;;=3^SCC Neop Skin,Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,11210,1,4,0)
 ;;=4^C44.1291
 ;;^UTILITY(U,$J,358.3,11210,2)
 ;;=^5157263
 ;;^UTILITY(U,$J,358.3,11211,0)
 ;;=C44.1292^^77^726^29
 ;;^UTILITY(U,$J,358.3,11211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11211,1,3,0)
 ;;=3^SCC Neop Skin,Left Lower Eyelid
 ;;^UTILITY(U,$J,358.3,11211,1,4,0)
 ;;=4^C44.1292
 ;;^UTILITY(U,$J,358.3,11211,2)
 ;;=^5157264
 ;;^UTILITY(U,$J,358.3,11212,0)
 ;;=H52.13^^77^727^36
 ;;^UTILITY(U,$J,358.3,11212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11212,1,3,0)
 ;;=3^Myopia,Bilateral
 ;;^UTILITY(U,$J,358.3,11212,1,4,0)
 ;;=4^H52.13
 ;;^UTILITY(U,$J,358.3,11212,2)
 ;;=^5006266
 ;;^UTILITY(U,$J,358.3,11213,0)
 ;;=H52.03^^77^727^33
 ;;^UTILITY(U,$J,358.3,11213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11213,1,3,0)
 ;;=3^Hypermetropia,Bilateral
 ;;^UTILITY(U,$J,358.3,11213,1,4,0)
 ;;=4^H52.03
 ;;^UTILITY(U,$J,358.3,11213,2)
 ;;=^5006262
 ;;^UTILITY(U,$J,358.3,11214,0)
 ;;=H52.4^^77^727^45
 ;;^UTILITY(U,$J,358.3,11214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11214,1,3,0)
 ;;=3^Presbyopia
 ;;^UTILITY(U,$J,358.3,11214,1,4,0)
 ;;=4^H52.4
 ;;^UTILITY(U,$J,358.3,11214,2)
 ;;=^98095
 ;;^UTILITY(U,$J,358.3,11215,0)
 ;;=H25.11^^77^727^10
 ;;^UTILITY(U,$J,358.3,11215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11215,1,3,0)
 ;;=3^Cataract,Nuclear Age-Rel,Right Eye
 ;;^UTILITY(U,$J,358.3,11215,1,4,0)
 ;;=4^H25.11
 ;;^UTILITY(U,$J,358.3,11215,2)
 ;;=^5005284
 ;;^UTILITY(U,$J,358.3,11216,0)
 ;;=H25.12^^77^727^9
 ;;^UTILITY(U,$J,358.3,11216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11216,1,3,0)
 ;;=3^Cataract,Nuclear Age-Rel,Left Eye
 ;;^UTILITY(U,$J,358.3,11216,1,4,0)
 ;;=4^H25.12
 ;;^UTILITY(U,$J,358.3,11216,2)
 ;;=^5005285
 ;;^UTILITY(U,$J,358.3,11217,0)
 ;;=Z98.49^^77^727^8
 ;;^UTILITY(U,$J,358.3,11217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11217,1,3,0)
 ;;=3^Cataract Extraction Status,Unspec Eye
 ;;^UTILITY(U,$J,358.3,11217,1,4,0)
 ;;=4^Z98.49
 ;;^UTILITY(U,$J,358.3,11217,2)
 ;;=^5063739
 ;;^UTILITY(U,$J,358.3,11218,0)
 ;;=H04.123^^77^727^23
 ;;^UTILITY(U,$J,358.3,11218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11218,1,3,0)
 ;;=3^Dry Eye Syndrome,Bilateral Lacrimal Glands
 ;;^UTILITY(U,$J,358.3,11218,1,4,0)
 ;;=4^H04.123
 ;;^UTILITY(U,$J,358.3,11218,2)
 ;;=^5004465
 ;;^UTILITY(U,$J,358.3,11219,0)
 ;;=H01.009^^77^727^6
 ;;^UTILITY(U,$J,358.3,11219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11219,1,3,0)
 ;;=3^Blepharitis,Unspec
 ;;^UTILITY(U,$J,358.3,11219,1,4,0)
 ;;=4^H01.009
 ;;^UTILITY(U,$J,358.3,11219,2)
 ;;=^5133381
 ;;^UTILITY(U,$J,358.3,11220,0)
 ;;=H40.023^^77^727^31
 ;;^UTILITY(U,$J,358.3,11220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11220,1,3,0)
 ;;=3^Glaucoma Suspect,High Risk,Bilateral
 ;;^UTILITY(U,$J,358.3,11220,1,4,0)
 ;;=4^H40.023
